Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea

키워드

참고문헌 (43)

1. Ferlay J, "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012", Int J Cancer, 136, pp.E359~E386 (2015)[DOI]
2. Shin A, "Validity of fecal occult blood test in the national cancer screening program, Korea", PLoS One, 8, pp.e79292~ (2013)[DOI]
3. Yoo KY, "Cancer control activities in the Republic of Korea", Jpn J Clin Oncol, 38, pp.327~333 (2008)[DOI]
4. Rembacken B, "Quality in screening colonoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE)", Endoscopy, 44, pp.957~968 (2012)[DOI]
5. Robertson DJ, "Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer", Gastrointest Endosc, 85, pp.2~21 (2017)[DOI]
6. Rizk MK, "Quality indicators common to all GI endoscopic procedures", Gastrointest Endosc, 81, pp.3~16 (2015)[DOI]
7. Jover R, "Clinical practice guidelines: quality of colonoscopy in colorectal cancer screening", Endoscopy, 44, pp.444~451 (2012)[DOI]
8. Jeon CH, "Annual report on external quality assessment scheme for urinalysis and faecal occult blood testing in Korea", J Lab Med Qual Assur, 37, pp.179~189 (2015)[DOI]
9. Omata F, "Diagnostic performance of quantitative fecal immunochemical test and multivariate prediction model for colorectal neoplasms in asymptomatic individuals", Eur J Gastroenterol Hepatol, 23, pp.1036~1041 (2011)
10. Fraser CG, "A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin", J Natl Cancer Inst, 104, pp.810~814 (2012)[DOI]
11. Dae Kyung Sohn, "Single Immunochemical Fecal Occult Blood Test for Detection of Colorectal Neoplasia", Cancer Research and Treatment, 37(1), pp.20~23 (2005), 대한암학회
12. Fenocchi E, "Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test", Eur J Cancer Prev, 15, pp.384~390 (2006)[DOI]
13. Lin OS, "Risk of proximal colorectal neoplasia among asymptomatic patients with distal hyperplastic polyps", Am J Med, 118, pp.1113~1119 (2005)[DOI]
14. Ruco A, "Evaluation of a risk index for advanced proximal neoplasia of the colon", Gastrointest Endosc, 81, pp.1427~1432 (2015)[DOI]
15. Schreiner MA, "Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia", Gastroenterology, 139, pp.1497~1502 (2010)[DOI]
16. Clark BT, "Quantification of adequate bowel preparation for screening or surveillance colonoscopy in men", Gastroenterology, 150, pp.396~405 (2016)[DOI]
17. Grazzini G, "Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results", Eur J Cancer Prev, 13, pp.19~26 (2004)[DOI]
18. Rozen P, "Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms", Aliment Pharmacol Ther, 29, pp.450~457 (2009)[DOI]
19. Crotta S, "High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test", Clin Gastroenterol Hepatol, 10, pp.633~638 (2012)[DOI]
20. Denters MJ, "Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer", Gastroenterology, 142, pp.497~504 (2012)[DOI]
21. Kapidzic A, "Attendance and yield over three rounds of population-based fecal immunochemical test screening", Am J Gastroenterol, 109, pp.1257~1264 (2014)[DOI]
22. McNamara D, "Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test", Eur J Gastroenterol Hepatol, 26, pp.1415~1421 (2014)
23. Parente F, "Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy", Endoscopy, 45, pp.27~34 (2013)[DOI]
24. Stegeman I, "Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening", Cancer Epidemiol, 39, pp.388~393 (2015)[DOI]
25. van Roon AH, "Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening", Gut, 62, pp.409~415 (2013)[DOI]
26. Jensen CD, "Fecal immunochemical test program performance over 4 rounds of annual screening: a retrospective cohort study", Ann Intern Med, 164, pp.456~463 (2016)[DOI]
27. Gupta S, "Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial", JAMA Intern Med, 173, pp.1725~1732 (2013)
28. Quintero E, "Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening", N Engl J Med, 366, pp.697~706 (2012)[DOI]
29. Segnan N, "Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening", Gastroenterology, 132, pp.2304~2312 (2007)[DOI]
30. Segnan N, "Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates", J Natl Cancer Inst, 97, pp.347~357 (2005)[DOI]
31. 서민아, "Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2013", Cancer Research and Treatment, 48(1), pp.1~10 (2016), 대한암학회[DOI]
32. Park MJ, "Trends in the National Cancer Screening Program for colorectal cancer in the Republic of Korea, 2004-2009", Asian Pac J Cancer Prev, 12, pp.3489~3493 (2011)
33. 신혜영, "Performance of the Fecal Immunochemical Test for Colorectal Cancer Screening Using Different Stool-Collection Devices: Preliminary Results from a Randomized Controlled Trial", Gut and Liver, 10(6), pp.925~931 (2016), 거트앤리버 소화기연관학회협의회
34. Park MJ, "A comparison of qualitative and quantitative fecal immunochemical tests in the Korean national colorectal cancer screening program", Scand J Gastroenterol, 47, pp.461~466 (2012)
35. NHS Bowel Cancer Screening Programme Quality Assurance Endoscopy Group, "Quality assurance guidelines for colonoscopy", NHS Cancer Screening Programmes, ~ (2011)
36. Rabeneck L, "Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice", Gastroenterology, 135, pp.1899~1906 (2008)[DOI]
37. Chubak J, "Time to colonoscopy after positive fecal blood test in four U.S. health care systems", Cancer Epidemiol Biomarkers Prev, 25, pp.344~350 (2016)[DOI]
38. Meester RG, "Consequences of increasing time to colonoscopy examination after positive result from fecal colorectal cancer screening test", Clin Gastroenterol Hepatol, 14, pp.1445~1451 (2016)[DOI]
39. Gellad ZF, "Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia", Dig Dis Sci, 54, pp.2497~2502 (2009)[DOI]
40. Rex DK, "Quality indicators for colonoscopy", Am J Gastroenterol, 110, pp.72~90 (2015)[DOI]
41. Hernandez V, "Fecal immunochemical test accuracy in average-risk colorectal cancer screening", World J Gastroenterol, 20, pp.1038~1047 (2014)[DOI]
42. Chen CH, "Fecal immunochemical test for colorectal cancer from a prospective cohort with 513,283 individuals: providing detailed number needed to scope (NNS) before colonoscopy", Medicine (Baltimore), 95, pp.e4414~ (2016)[DOI]
43. Liao CS, "Application of quantitative estimates of fecal hemoglobin concentration for risk prediction of colorectal neoplasia", World J Gastroenterol, 19, pp.8366~8372 (2013)[DOI]

관련 논문AI추천